Related references
Note: Only part of the references are listed.Corticosteroid exposure and cumulative effects in patients with eczema Results from a patient survey
Kelly Barta et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)
Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions
Razvigor Darlenski et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis
Ellen S. Koster et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons
Anne Sofie Frolunde et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)
A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence
Marika Quadri et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2021)
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis
Enea Gino Di Domenico et al.
MICROORGANISMS (2019)
Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers
Bernies Bos et al.
PEDIATRIC DERMATOLOGY (2019)
Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score
Lies Lambrechts et al.
ACTA DERMATO-VENEREOLOGICA (2019)
A randomized, open-label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis
Lian Liu et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines
Lawrence F. Eichenfield et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Clinical efficacy of emollients in atopic dermatitis patients - relationship with the skin microbiota modification
Sophie Seite et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis
Pascale Bianchi et al.
PEDIATRIC DERMATOLOGY (2016)
Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Heidi H. Kong et al.
GENOME RESEARCH (2012)
Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe
J. -F. Stalder et al.
ALLERGY (2011)
Management of Itch in Atopic Dermatitis
Judith Hong et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2011)
Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study
A. Gueniche et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms
A. Gueniche et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
A systematic review of the safety of topical therapies for atopic dermatitis
J. Callen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)